SCOPUS 정보 검색 플랫폼

Volumn 124, Issue 2, 2002, Pages 96-103

New aspects by the therapy of ovarian cancer - What changes after the ASCO-meeting 2001?;Neue aspekte bei der therapie des ovarialkarzinoms - Was ändert sich nach dem ASCO-meeting 2001?

(4) Costa, Serban D a Von Minckwitz, G a Wernicke, K a Kaufmann, M a

a UNIVERSITY HOSPITAL FRANKFURT (Germany)

Author keywords

ASCO; Multimodal therapy; Ovarian cancer; Therapy

Indexed keywords

ACYLFULVENE DERIVATIVE; ANTIBODY; ANTIINFECTIVE AGENT; ANTISENSE OLIGONUCLEOTIDE; CA 125 ANTIGEN; CARBOPLATIN; CGP 69846A; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPOTHILONE DERIVATIVE; ERLOTINIB; METALLOPROTEINASE INHIBITOR; PACLITAXEL; PLATINUM DERIVATIVE; PROTEIN INHIBITOR; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; OVARY CANCER; REVIEW; SIDE EFFECT; WESTERN EUROPE;

EID: 0036213368 PISSN: 00444197 EISSN: None Source Type: Journal
DOI: 10.1055/s-2002-24240 Document Type: Review

Times cited : (1)

References (25)

1
- 0031985166
- Survival and prognostic factors of early ovarian cancer
- (1998) Br J Cancer , vol.77 , pp. 123-124
- Villa, A.¹ Parazzini, F.² Acerboni, S.³ Guarnerio, P.⁴ Bolis, G.⁵

2
- 85008410149
- Can patients with relapsed previously untreated stage 1 epithelial ovarian cancer be salvaged?
- Abstract 803
- (2001) Proc Am Soc Clin Oncol
- Kolomainen, D.F.¹ A'Hern, R.² Gore, M.³

3
- 0001326134
- Results of a randomized trial in 923 patients with high-risk early ovarian cancer, comparing adjuvant chemotherapy with no further treatment following surgery
- Abstract 802
- (2001) Proc Am Soc Clin Oncol
- Vergote, I.B.¹ Trimbos, B.J.² Guthrie, D.³ Parmar⁴ Bolis, G.⁵ Mangioni, C.⁶ Anastasopolou, A.⁷ Toni, V.⁸ Vermorken, J.⁹

4
- 0001671915
- Preliminary results of the SCOTROC trial: A phase III comparison of paclitaxel-carboplatin (PC) and docetaxel-carboplatin (DC) as first-line chemotherapy for stage IC-IV epithelial ovarian cancer
- Abstract 804
- (2001) Proc Am Soc Clin Oncol
- Vasey, P.¹

5
- 0000367402
- Epirubicin/paclitaxel/carboplatin (TEC) versus paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO Stages IIB-IV. Interim results of an AGO-GINECO intergroup phase III trial
- Abstract 805
- (2001) Proc Am Soc Clin Oncol
- Du Bois, A.¹ Weber, B.² Pfisterer, J.³ Groupil, A.⁴ Wagner, U.⁵ Barats, J.⁶ Olbrich, S.⁷ Mousseau, M.⁸ Nitz, U.⁹ Meden, H.¹⁰

6
- 17744372884
- Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
- (2001) Br J Cancer , vol.84 , pp. 170-178
- Vasey, P.A.¹ Atkinson, R.² Coleman, R.³

7
- 0345251967
- First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer; a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group
- (1999) J Clin Oncol , vol.17 , pp. 46-51
- Du Bois, A.¹ Luck, H.J.² Bauknecht, T.³

8
- 0030054309
- Cyclophosphamide and cisplatin with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

9
- 0003164642
- Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer
- German AGO Study Group Ovarian Cancer. ArbeitsgemeinschaftGynäkologische Onkologie
- (1997) Semin Oncol , vol.24 , pp. 11-28
- Du Bois, A.¹ Lück, H.J.² Meier, W.³ Möbus, V.⁴ Costa, S.D.⁵ Richter, B.⁶ Bauknecht, T.⁷ Warm, M.⁸ Schröder, W.⁹ Olbricht, S.¹⁰ Nitz, U.¹¹ Jackisch, C.¹²

10
- 0034600305
- Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
- (2000) J Natl Cancer Inst , vol.92 , pp. 699-708
- Piccart, M.J.¹ Bertelsen, K.² James, K.³ Cassidy, J.⁴ Mangioni, C.⁵ Simonsen, E.⁶ Stuart, G.⁷ Kaye, S.⁸ Vergote, I.⁹ Blom, R.¹⁰ Grimshaw, R.¹¹ Atkinson, R.J.¹² Swenerton, K.D.¹³ Trope, C.¹⁴ Nardi, M.¹⁵ Kaern, J.¹⁶ Tumolo, S.¹⁷ Timmers, P.¹⁸ Roy, J.A.¹⁹ Lhoas, F.²⁰ more..

11
- 2042536059
- in press
- (2001) Medikamentöse Primärtherapie beim fortgeschrittenen epithelialen Ovarialkarzinorn Der Gynäkologe
- Costa, S.D.¹ Möbus, V.² Meden, H.³

12
- 0003335157
- Carboplatin and paclitaxel as initial second-line therapy in recurrent epithelial ovarian carcinoma
- Abstract 809
- (2001) Proc Am Soc Clin Oncol
- Dizon, D.¹ Hensley, M.² Sabbatine, P.³ Poynor, E.⁴ Hummer, A.⁵ Venkatraman, E.⁶ Spriggs, D.⁷

13
- 0033580350
- Stammzellgestützte hochdosischernotherapie (HDCT) in der primärbehandlung des fortgeschrittenen ovarialkarzinoms
- (1999) Schweiz Rundsch Med Prax , vol.88 , pp. 507-512
- Möbus, V.¹ Von Schilling, C.² Kreienberg, R.³ Wiesneth, M.⁴ Bergmann, L.⁵ Frickhofen, N.⁶

14
- 0001173538
- Phase III Randomized Trial of high-dose chemotherapy and peripheral blood stem cell support as consolidation in patients with responsive low-burden advanced ovarian cancer: Preliminary results of a GI-NECO/FNCLCC/SFGM-TC study
- Abstract 815
- (2001) Proc Am Soc Clin Oncol
- Cure, H.¹ Battista, C.² Guastalla, G.P.³ Fabbro, M.⁴ Tubiana-Mathieu, N.⁵ Bourgeois, H.⁶ Lioure, B.⁷ Lhomme, C.⁸ Chiurazzi, B.⁹ Paraiso, D.¹⁰ Pujade-Lauraine, E.¹¹

15
- 0000367404
- Survival impact of maximum cytoreductive surgery in advanced ovarian carcinoma during the platinum era: A meta-analysis of 6 848 patients
- Abstract 807
- (2001) Proc Am Soc Clin Oncol
- Bristow, R.E.¹ Tomacruz, R.S.² Armstrong, D.K.³ Trimble, E.L.⁴ Montz, F.J.⁵

16
- 0029156963
- Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: Correlation with clinical outcome and response to chemotherapy
- (1995) Br J Cancer , vol.72 , pp. 361-366
- Scambia, G.¹ Benedetti-Panici, P.² Ferrandina, G.³

17
- 0001069404
- Phase 2 evaluation of OSI-774, a potent oral antagonist of the EGFR-TK in patients with advanced ovarian carcinoma
- Abstract 831
- (2001) Proc Am Soc Clin Oncol
- Finkler, N.¹ Gordon, A.² Crozier, M.³ Edwards, R.⁴ Figueroa, J.⁵ Garcia, A.⁶ Hainsworth, J.⁷ Irwin, D.⁸ Silberman, S.⁹ Allen, L.¹⁰ Ferrante, K.¹¹ Fisher, D.¹² Nadler, P.¹³

18
- 0003197370
- Phase II study of irofulven in platinum-resistant recurrent ovarian cancer
- Abstract 868
- (2001) Proc Am Soc Clin Oncol
- Sarosy, G.A.¹ Kotz, H.² Smith, S.³ Murgo, A.⁴ Minasian, L.⁵ Dywer, V.⁶ Kohler, D.⁷ Kim, S.⁸ Reed, E.⁹

19
- 4243444233
- Effects of irofulven (MGI 114) on telomerase activity in human tumor cell lines
- Proc NCI-EORTC-AACR Symposium on new drugs in cancer therapy
- (2000) Suppl Clin Cancer Res , vol.6
- Davidson, K.¹ Sun, D.² Young, R.S.³

20
- 0034678986
- Epothilones and related structures-a new class of microtubule inhibitors with potent in vivo antitumor activity
- (2000) Biochem Biophys Acta , vol.1470
- Altmann, K.H.¹ Wartmann, M.² O'Reilly, T.³

21
- 0034903353
- New natural epothilones from Sorangiurn cellulosum, strains So ce90/B2 and So ce90/D13: Isolation, structure elucidation, and SAR studies
- (2001) J Nat Prod , vol.64 , pp. 847-856
- Hardt, I.H.¹ Steinmetz, H.² Gerth, K.³ Sasse, F.⁴ Reichenbach, H.⁵ Hofle, G.⁶

22
- 0003264497
- Phase I evaluation of an epothilone B analog (BMS-247550): Clinical findings and molecular correlates
- Abstract 269
- (2001) Proc Am Soc Clin Oncol
- Mani, S.¹ McDaid, H.² Shen, H.³ Sparano, J.A.⁴ Hamilton, A.⁵ Runowicz, C.⁶ Höchster, H.⁷ Muggia, F.⁸ Fields, A.⁹ Damle, B.¹⁰ Letrent, S.¹¹ Lebwohl, D.¹² Horwüz, S.B.¹³

23
- 0003200099
- A phase I and pharmacologic trial of weekly epothilone B in patients with advanced malignancies
- Abstract 270
- (2001) Proc Am Soc Clin Oncol
- Rubin, E.H.¹ Sw, L.L.² Beers, S.³ Moore, M.J.⁴ Thompson, C.⁵ Becher, M.⁶ Chen, T.L.⁷ Cohen, P.⁸ Rothermel, J.⁹ Oza, A.M.¹⁰

24
- 0003206565
- Antisense Oligonucleotide (ISIS 5132) targeting of c-raf-kinase in ovarian cancer models
- Abstract 833
- (2001) Proc Am Soc Clin Oncol
- Langdon, S.¹ McPhillips, F.² Mullen, P.³ Ritchie, A.⁴ Smyth, J.⁵ Monia, B.⁶ Dorr, A.⁷

25
- 0007690612
- Interim analysis of a double blind study of Ovarex™ mAb B43.13 (OV) versus placebo (PBO) in patients with ovarian cancer
- Abstract 837
- (2001) Proc Am Soc Clin Oncol
- Berek, J.¹ Ehlen, T.² Gordon, A.³ Nicodemus, C.⁴ Schultes, B.⁵ Whiteside, T.⁶ Noujaim, A.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.